Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
61 studies found for:    "Primary sclerosing cholangitis"
Show Display Options
Rank Status Study
21 Recruiting Safety, Tolerability, and Efficacy of GS-9674 in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: GS-9674;   Drug: Placebo to match GS-9674
22 Completed Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Subjects With Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Interventions: Biological: Simtuzumab;   Biological: Placebo
23 Active, not recruiting Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Interventions: Drug: OCA;   Drug: Placebo
24 Completed Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Drug: LUM001
25 Recruiting Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures
Condition: Primary Sclerosing Cholangitis
Intervention: Device: probe based confocal laser endomicroscopy
26 Recruiting Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.
Condition: Sclerosing Cholangitis
Intervention: Biological: Fecal Microbiota Transplantation
27 Recruiting Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Conditions: Primary Sclerosing Cholangitis;   Biliary Atresia
Intervention: Drug: Oral Vancomycin
28 Completed
Has Results
Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Conditions: Primary Sclerosing Cholangitis;   Biliary Atresia
Intervention: Drug: Vancomycin
29 Recruiting A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Intervention: Drug: Vancomycin
30 Unknown  NPD Measurements in PSC Patients
Condition: Primary Sclerosing Cholangitis
Intervention:
31 Recruiting Genomics of Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Genetic: Genetic Analysis
32 Completed Trial of High-dose Urso in Primary Sclerosing Cholangitis
Condition: Sclerosing Cholangitis
Intervention: Drug: Ursodeoxycholic Acid
33 Completed A Pilot Study of Xifaxan to Treat Patients With PSC
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Drug: Xifaxan
34 Completed Clinical Utility of the Spyglass System in Primary Sclerosing Cholangitis (PSC)
Condition: Sclerosing Cholangitis
Intervention:
35 Terminated
Has Results
Fenofibrate for PSC
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: fenofibrate
36 Recruiting Secondary Sclerosing Cholangitis in Critically Ill Patients
Condition: Secondary Sclerosing Cholangitis
Intervention:
37 Completed Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
Conditions: Primary Sclerosing Cholangitis;   Trisomy 7;   Cholangiocarcinoma;   Chemoprevention
Intervention: Drug: Erlotinib (Tarceva)
38 Completed Evaluation of DHA for the Treatment of PSC
Conditions: Primary Sclerosing Cholangitis;   Colitis
Intervention: Drug: Docosahexaenoic Acid (DHA)
39 Completed Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis
Conditions: Ulcerative Colitis;   Primary Sclerosing Cholangitis;   Pouchitis;   Complications
Intervention:
40 Unknown  Telomere Length and Other Parameters of Telomere Dysfunction in PSC and Colitis
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.